Detection and Sizing of Submicron Particles in Biologics With Interferometric Scattering Microscopy

J Pharm Sci. 2020 Jan;109(1):881-890. doi: 10.1016/j.xphs.2019.05.003. Epub 2019 May 31.

Abstract

We demonstrate the application of interferometric scattering microscopy (IFS) for characterizing submicron particles in stir-stressed monoclonal antibody. IFS uses a layered silicon sensor and modified optical microscope to rapidly visualize and determine the particle size distribution (PSD) of submicron particles based on their scattering intensity, which is directly proportional to particle mass. Limits for particle size and optimal solution concentration were established for IFS characterization of submicron particles. We critically compare IFS data with dynamic light scattering (DLS) and nanoparticle tracking analysis (NTA) and find IFS is superior to NTA and DLS for determining the realistic shape of the number-based PSD, whereas NTA and DLS provide superior information about absolute particle size. Together, IFS, NTA, and DLS provide complementary information on submicron particles and enable quantitative characterization of the PSD of submicron aggregates. Finally, we explore quantifying particle size with IFS by developing a calibration curve for particle scattering intensity based on correlative scanning electron microscopy imaging. We found that only a subset of isotropic-shaped particles followed the expected proportionality between IFS intensity and particle mass. Overall, this study demonstrates IFS is a simple approach for detecting and quantifying submicron aggregate PSD in protein-based therapeutics.

Keywords: biopharmaceutical characterization; image analysis; nanoparticle(s); physical characterization; physical stability; protein aggregation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / chemistry*
  • Biological Products / chemistry*
  • Drug Compounding
  • Drug Stability
  • Dynamic Light Scattering
  • Microscopy, Interference*
  • Nanotechnology
  • Particle Size
  • Protein Aggregates
  • Protein Stability

Substances

  • Antibodies, Monoclonal
  • Biological Products
  • Protein Aggregates